161 related articles for article (PubMed ID: 21374663)
1. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.
Yeoman AD; Westbrook RH; Zen Y; Maninchedda P; Portmann BC; Devlin J; O'Grady JG; Harrison PM; Heneghan MA
Hepatology; 2011 Mar; 53(3):926-34. PubMed ID: 21374663
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
[TBL] [Abstract][Full Text] [Related]
3. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease.
Montano-Loza AJ; Carpenter HA; Czaja AJ
Hepatology; 2007 Oct; 46(4):1138-45. PubMed ID: 17668882
[TBL] [Abstract][Full Text] [Related]
4. [The value of the baseline MELD scores, MELD-Na scores and iMELD scores in short-term prognosis in hepatitis B virus related acute-on-chronic liver failure patients].
Li C; You S; Liu H; Liu W; Wan Z; Tang G; Xin S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug; 26(8):539-43. PubMed ID: 25124900
[TBL] [Abstract][Full Text] [Related]
5. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score.
De Martin E; Coilly A; Chazouillères O; Roux O; Peron JM; Houssel-Debry P; Artru F; Silvain C; Ollivier-Hourmand I; Duvoux C; Heurgue A; Barge S; Ganne-Carrié N; Pageaux GP; Besch C; Bourlière M; Fontaine H; de Ledinghen V; Dumortier J; Conti F; Radenne S; Debette-Gratien M; Goria O; Durand F; Potier P; Di Martino V; Reboux N; Ichai P; Sebagh M; Mathurin P; Agostini H; Samuel D; Duclos-Vallée JC;
J Hepatol; 2021 Jun; 74(6):1325-1334. PubMed ID: 33503489
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
[TBL] [Abstract][Full Text] [Related]
7. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
8. The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose.
Craig DG; Reid TW; Wright EC; Martin KG; Davidson JS; Hayes PC; Simpson KJ
Aliment Pharmacol Ther; 2012 Mar; 35(6):705-13. PubMed ID: 22260637
[TBL] [Abstract][Full Text] [Related]
9. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
Wagener G; Raffel B; Young AT; Minhaz M; Emond J
Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
[TBL] [Abstract][Full Text] [Related]
10. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of MELD-Na versus MELDNa in the prediction of short-term prognosis for acute-on-chronic hepatitis B liver failure].
He WP; Hu JH; Tong JJ; Liu FF; Wang HF
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1173-7. PubMed ID: 21756769
[TBL] [Abstract][Full Text] [Related]
12. [An evaluation of the prognosis of patients with chronic severe hepatitis using a model for end-stage liver disease].
Cai CJ; Lu MQ; Cong YT; Chen HA; Chen GH
Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):408-11. PubMed ID: 17594802
[TBL] [Abstract][Full Text] [Related]
13. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
[TBL] [Abstract][Full Text] [Related]
14. Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy.
Westbrook RH; Yeoman AD; O'Grady JG; Harrison PM; Devlin J; Heneghan MA
Clin Gastroenterol Hepatol; 2011 Aug; 9(8):694-9. PubMed ID: 21570482
[TBL] [Abstract][Full Text] [Related]
15. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria.
Dhiman RK; Jain S; Maheshwari U; Bhalla A; Sharma N; Ahluwalia J; Duseja A; Chawla Y
Liver Transpl; 2007 Jun; 13(6):814-21. PubMed ID: 17370333
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acute-on-chronic hepatitis B liver failure.
He WP; Hu JH; Zhao J; Tong JJ; Ding JB; Lin F; Wang HF
Chin Med J (Engl); 2012 Jul; 125(13):2272-8. PubMed ID: 22882847
[TBL] [Abstract][Full Text] [Related]
17. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
[TBL] [Abstract][Full Text] [Related]
18. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
Cuomo O; Perrella A; Arenga G
Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
[TBL] [Abstract][Full Text] [Related]
19. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
[TBL] [Abstract][Full Text] [Related]
20. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
